Trial intelligence / Profile preview

Multicenter randomized trial of Jingushang spray for acute soft tissue injury

ChiCTR2000034303Phase 4Not yet recruiting

Sponsor
Peking University Third Hospital
Start
Jun 2020
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of jingushang in soft tissue injury (3 arms), sponsored by Peking University Third Hospital. Primary endpoint: Time to pain disappearance. Planned start Jun 2020; status: not yet recruiting.

02

Drugs

jingushang
03

Conditions

soft tissue injury

Beyond the preview

Go deeper on ChiCTR2000034303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call